The DOI matches its Crossref record; 51 of the 51 references it cites were found in a registry or an index.
The metabolism and anti-atherogenic properties of HDL
Open accessAbstract
Population studies have shown that plasma HDL levels correlate inversely with cardiovascular disease risk. In recent years there has been intense interest in developing strategies for exploiting these cardioprotective properties by increasing HDL levels. While this approach has considerable merit, it is important to recognize that HDL are structurally and functionally diverse and consist of numerous, highly dynamic subpopulations of particles that do not all inhibit atherosclerosis to the same extent. For this reason it is essential to assess HDL subpopulation distribution and functionality when considering therapeutic interventions that raise HDL levels. This review documents what is known about the relationship between the metabolism and function of HDL subpopulations and how this affects their cardioprotective properties.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Lowered levels of lipoprotein sub-fractions HDL2 and HDL3 are considered to increase CVD risk, although HDL3 may be less protective in the presence of MetS [15].”
Citations
Cites
High-density lipoprotein cholesterol and cardiovascular disease. Four prospective American studies.
Gordon, D. J., Probstfield, J. L., Garrison, R. J., Neaton, J. D., Castelli, W. P., Knoke, J. D., Jacobs, D. R., Bangdiwala, S., & Tyroler, H. A. (1989) · Circulation · doi:10.1161/01.cir.79.1.8 · Cited by 3,162
Effects of torcetrapib in patients at high risk for coronary events
Barter, P. J., Caulfield, M., Eriksson, M., Grundy, S. M., Kastelein, J. J. P., Komajda, M., Lopez-Sendon, J., Mosca, L., Tardif, J.-C., Waters, D. D., et al. (2007) · New England Journal of Medicine · doi:10.1056/nejmoa0706628 · Cited by 3,139
Self-citationIdentification of Scavenger Receptor SR-BI as a High Density Lipoprotein Receptor
Acton, S., Rigotti, A., Landschulz, K. T., Xu, S., Hobbs, H. H., & Krieger, M. (1996) · Science · doi:10.1126/science.271.5248.518 · Cited by 2,026
HDL cholesterol, very low levels of LDL cholesterol, and cardiovascular events
Barter, P., Gotto, A. M., LaRosa, J. C., Maroni, J., Szarek, M., Grundy, S. M., Kastelein, J. J. P., Bittner, V., & Fruchart, J.-C. (2007) · New England Journal of Medicine · doi:10.1056/nejmoa064278 · Cited by 1,610
Self-citationNew Insights Into the Regulation of HDL Metabolism and Reverse Cholesterol Transport
Lewis, G. F., & Rader, D. J. (2005) · Circulation Research · doi:10.1161/01.res.0000170946.56981.5c · Cited by 1,104
Effect of Torcetrapib on the Progression of Coronary Atherosclerosis
Nissen, S. E., Tardif, J., Nicholls, S. J., Revkin, J. H., Shear, C. L., Duggan, W. T., Rużyłło, W., Bachinsky, W., Lasala, G. P., & Tuzcu, E. M. (2007) · New England Journal of Medicine · doi:10.1056/nejmoa070635 · Cited by 968
High-Density Lipoproteins Inhibit Cytokine-Induced Expression of Endothelial Cell Adhesion Molecules
COCKERILL, G. W., Rye, K., Gamble, J. R., Vadas, M. A., & Barter, P. J. (1995) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.15.11.1987 · Cited by 788
Self-citationEffects of an Inhibitor of Cholesteryl Ester Transfer Protein on HDL Cholesterol
Brousseau, M. E., Schaefer, E. J., Wolfe, M. L., Bloedon, L. T., Digenio, A. G., Clark, R. W., Mancuso, J. P., & Rader, D. J. (2004) · New England Journal of Medicine · doi:10.1056/nejmoa031766 · Cited by 774
Badimón, J. J., Badimón, L., & Fuster, V. (1990) · Journal of Clinical Investigation · doi:10.1172/jci114558 · Cited by 764
Endothelial and Antithrombotic Actions of HDL
Mineo, C., Deguchi, H., Griffin, J. H., & Shaul, P. W. (2006) · Circulation Research · doi:10.1161/01.res.0000225982.01988.93 · Cited by 663
Early incorporation of cell-derived cholesterol into pre-.beta.-migrating high-density lipoprotein
Castro, G. R., & Fielding, C. J. (1988) · Biochemistry · doi:10.1021/bi00401a005 · Cited by 641
Characterization of human high-density lipoproteins by gradient gel electrophoresis
Blanche, P. J., Gong, E. L., Forte, T. M., & Nichols, A. V. (1981) · Biochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism · doi:10.1016/0005-2760(81)90253-8 · Cited by 614
High-Density Lipoprotein Reduces the Human Monocyte Inflammatory Response
Murphy, A. J., Woollard, K. J., Hoang, A., Mukhamedova, N., Stirzaker, R. A., McCormick, S. P. A., Remaley, A. T., Sviridov, D., & Chin-Dusting, J. P. F. (2008) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.108.168690 · Cited by 511
Lecithin cholesterol acyltransferase
Jonas, A. (2000) · Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids · doi:10.1016/s1388-1981(00)00153-0 · Cited by 477
Hansel, B., Giral, P., Nobécourt, E., Chantepie, S., Bruckert, É., Chapman, M. J., & Kontush, A. (2004) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2004-0305 · Cited by 476
Cheung, M. C., & Albers, J. J. (1984) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(20)71339-6 · Cited by 473
Bots, M. L., Visseren, F. L. J., Evans, G. W., Riley, W. A., Revkin, J. H., Tegeler, C. H., Shear, C. L., Duggan, W. T., Vicari, R. M., Grobbee, D. E., et al. (2007) · The Lancet · doi:10.1016/s0140-6736(07)61088-5 · Cited by 458
Small, Dense HDL Particles Exert Potent Protection of Atherogenic LDL Against Oxidative Stress
Kontush, A., Chantepie, S., & Chapman, M. J. (2003) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.0000091338.93223.e8 · Cited by 452
A novel endothelial-derived lipase that modulates HDL metabolism
Jaye, M., Lynch, K. J., Krawiec, J., Marchadier, D., Maugeais, C., Doan, K., South, V., Amin, D., Perrone, M., & Rader, D. J. (1999) · Nature Genetics · doi:10.1038/7766 · Cited by 427
ATP-Binding Cassette Cholesterol Transporters and Cardiovascular Disease
Oram, J. F., & Vaughan, A. M. (2006) · Circulation Research · doi:10.1161/01.res.0000250171.54048.5c · Cited by 411
Regression of Atherosclerosis Induced by Liver-Directed Gene Transfer of Apolipoprotein A-I in Mice
Tangirala, R. K., Tsukamoto, K., Chun, S. H., Usher, D. C., Puré, E., & Rader, D. J. (1999) · Circulation · doi:10.1161/01.cir.100.17.1816 · Cited by 355
Oxidation of High Density Lipoproteins
Garner, B., Waldeck, A. R., Witting, P. K., Rye, K.-A., & Stocker, R. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.11.6088 · Cited by 324
Self-citationFormation and Metabolism of Prebeta-Migrating, Lipid-Poor Apolipoprotein A-I
Rye, K., & Barter, P. J. (2003) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.0000104029.74961.f5 · Cited by 307
Self-citationMatsuura, F. (2006) · Journal of Clinical Investigation · doi:10.1172/jci27602 · Cited by 296
Nicholls, S. J., Dusting, G. J., Cutri, B., Bao, S., Drummond, G. R., Rye, K., & Barter, P. J. (2005) · Circulation · doi:10.1161/01.cir.0000159351.95399.50 · Cited by 294
Self-citationQiu, X., Mistry, A., Ammirati, M. J., Chrunyk, B. A., Clark, R. W., Cong, Y., Culp, J. S., Danley, D. E., Freeman, T. B., Geoghegan, K. F., et al. (2007) · Nature Structural & Molecular Biology · doi:10.1038/nsmb1197 · Cited by 280
Oxidation of High Density Lipoproteins
Garner, B., Witting, P. K., Waldeck, A. R., Christison, J. K., Raftery, M. J., & Stocker, R. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.11.6080 · Cited by 278
Ashby, D. T., Rye, K., Clay, M. A., Vadas, M. A., Gamble, J. R., & Barter, P. J. (1998) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.18.9.1450 · Cited by 199
Self-citationMa, K., Cilingiroglu, M., Otvos, J. D., Ballantyne, C. M., Marian, A. J., & Chan, L. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0438039100 · Cited by 189
Huang, Y., von Eckardstein, A., Wu, S., Maeda, N., & Assmann, G. (1994) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.91.5.1834 · Cited by 180
High-Density Lipoproteins Enhance Progenitor-Mediated Endothelium Repair in Mice
Tso, C., Martinic, G., Fan, W.-H., Rogers, C., Rye, K., & Barter, P. J. (2006) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.0000216600.37436.cf · Cited by 178
Self-citationMorehouse, L. A., Sugarman, E. D., Bourassa, P.-A. K., Sand, T. M., Zimetti, F., Gao, F., Rothblat, G. H., & Milici, A. J. (2007) · Journal of Lipid Research · doi:10.1194/jlr.m600332-jlr200 · Cited by 173
Antioxidant and cytoprotective properties of high-density lipoproteins in vascular cells
Nègre‐Salvayre, A., Dousset, N., Ferretti, G., Bacchetti, T., CURATOLA, G., & Salvayre, R. (2006) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2006.07.006 · Cited by 162
Baker, P. W., Rye, K., Gamble, J. R., Vadas, M. A., & Barter, P. J. (2000) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)33434-9 · Cited by 133
Self-citationThe Mechanism of the Remodeling of High Density Lipoproteins by Phospholipid Transfer Protein
Settasatian, N., Duong, M., Curtiss, L. K., Ehnholm, C., Jauhiainen, M., Huuskonen, J., & Rye, K.-A. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m010708200 · Cited by 131
Self-citationBelalcazar, L. M., Merched, A. J., Carr, B. K., Oka, K., Chen, K., Pastore, L., Beaudet, A. L., & Chan, L. (2003) · Circulation · doi:10.1161/01.cir.0000066913.69844.b2 · Cited by 127
Clay, M. A., Newnham, H. H., & Barter, P. J. (1991) · Arteriosclerosis and Thrombosis A Journal of Vascular Biology · doi:10.1161/01.atv.11.2.415 · Cited by 109
Self-citationRye, K., Hime, N. J., & Barter, P. J. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.7.3953 · Cited by 100
Self-citationde Beer, M. C., Durbin, D. M., Cai, L., Mirocha, N., Jonas, A., Webb, N. R., de Beer, F. C., & van der Westhuyzen, D. R. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m100228200 · Cited by 72
Yoshikawa, M., SAKUMA, N., Hibino, T., Sato, T., & Fujinami, T. (1997) · Clinical Biochemistry · doi:10.1016/s0009-9120(97)00031-3 · Cited by 72
Asztalos, B. F., Collins, D., Horvath, K. V., Bloomfield, H. E., Robins, S. J., & Schaefer, E. J. (2008) · Metabolism · doi:10.1016/j.metabol.2007.08.009 · Cited by 71
Valenta, D. T., Ogier, N., Bradshaw, G. P., Black, A. S., Bonnet, D. J., Lagrost, L., Curtiss, L. K., & Desrumaux, C. M. (2006) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.0000225700.43836.ae · Cited by 62
Jahangiri, A., Rader, D. J., Marchadier, D. H. L., Curtiss, L. K., Bonnet, D. J., & Rye, K.-A. (2005) · Journal of Lipid Research · doi:10.1194/jlr.m400212-jlr200 · Cited by 54
Self-citationRye, K.-A., Wee, K., Curtiss, L. K., Bonnet, D. J., & Barter, P. J. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m213250200 · Cited by 53
Self-citationHime, N. J., Barter, P. J., & Rye, K. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.42.27191 · Cited by 38
Self-citationMoren, X., Deakin, S., Liu, M., Taskinen, M., & James, R. W. (2008) · Journal of Lipid Research · doi:10.1194/jlr.m700439-jlr200 · Cited by 37
Rye, K.-A., Duong, M., Psaltis, M., Curtiss, L. K., Bonnet, D. J., Stocker, R., & Barter, P. J. (2002) · Biochemistry · doi:10.1021/bi025998k · Cited by 33
Self-citationRinninger, F., Brundert, M., Budzinski, R.-M., Fruchart, J., Greten, H., & Castro, G. R. (2002) · Atherosclerosis · doi:10.1016/s0021-9150(02)00311-8 · Cited by 27
van Haperen, R., Samyn, H., Moerland, M., van Gent, T., Peeters, M. C. E., Grosveld, F. G., van Tol, A., & de Crom, R. (2008) · PLoS ONE · doi:10.1371/journal.pone.0002255 · Cited by 27
Hepatic lipase: Friend or foe and under what circumstances?
Jansen, H. (2004) · Current Atherosclerosis Reports · doi:10.1007/s11883-004-0044-3 · Cited by 25
Caiazza, D., Jahangiri, A., Rader, D. J., Marchadier, D. H. L., & Rye, K. (2004) · Biochemistry · doi:10.1021/bi049776t · Cited by 16
Self-citation
Cited by
Sorted by citations
Progress and challenges in translating the biology of atherosclerosis
Libby, P., Ridker, P. M., & Hansson, G. K. (2011) · Nature · doi:10.1038/nature10146 · Cited by 4,010
Chapman, M. J., Ginsberg, H. N., Amarenco, P., Andreotti, F., Borén, J., Catapano, A. L., Descamps, O. S., Fisher, E., Kovanen, P. T., Kuivenhoven, J. A., et al. (2011) · European Heart Journal · doi:10.1093/eurheartj/ehr112 · Cited by 1,227
MicroRNAs in metabolism and metabolic disorders
Rottiers, V., & Näär, A. M. (2012) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm3313 · Cited by 1,156
HDL and cardiovascular disease: atherogenic and atheroprotective mechanisms
Navab, M., Reddy, S. T., Lenten, B. J. V., & Fogelman, A. M. (2011) · Nature Reviews Cardiology · doi:10.1038/nrcardio.2010.222 · Cited by 666
Schalkwijk, C., & Stehouwer, C. D. A. (2019) · Physiological Reviews · doi:10.1152/physrev.00001.2019 · Cited by 649
Metadata
- Authors
- Rye, K.-A., Bursill, C. A., Lambert, G., Tabet, F., & Barter, P. J.
- Affiliations
- The University of Sydney (AU)
- The Heart Research Institute (AU)
- Corresponding author
- Rye, Kerry-Anne
- Venue
- Journal of Lipid Research
- Publisher
- Elsevier BV
- Published
- 2009-04
- Volume
- 50
- Pages
- S195-S200
- ISSN
- 0022-2275 (ISSN-L)
- PMC
- PMC2674714
- OpenAlex
- W1967702791
- Cited by
- 331
- References
- 51
- Citations by year
- 2026: 13 · 2025: 14 · 2024: 12 · 2023: 17 · 2022: 15 · 2021: 16 · 2020: 16 · 2019: 17 · 2018: 21 · 2017: 13 · 2016: 9 · 2015: 27 · 2014: 21 · 2013: 48 · 2012: 20
- FWCI
- 2.90
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- Locations
- Journal of Lipid Research (publishedVersion, cc-by)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Biochemistry › Cholesterol and Lipid Metabolism
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Lipoproteins and Cardiovascular Health
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Clinical Biochemistry › Paraoxonase enzyme and polymorphisms
- Keywords
- HDL metabolism, HDL subpopulations, atherosclerosis, cardioprotection, cardiovascular risk, HDL function, HDL-targeted therapy
- MeSH terms
- Animals, Antioxidants, Humans, Inflammation, Cholesterol, HDL, Genetic Heterogeneity, Atherosclerosis
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review